AI Article Synopsis
- The study found that using mobile stroke units (MSUs) improved quality of life and reduced disability for ischemic stroke patients, but came with higher costs.
- The economic evaluation revealed that dispatching MSUs resulted in an incremental cost of €40,984 per quality-adjusted life year (QALY) gained, with varying scenarios showing costs ranging from €24,470.76 to €61,690.88 per QALY.
- Overall, MSU dispatch was deemed cost-effective according to accepted thresholds, meaning the benefits in patient quality of life justified the extra expenses involved.
Article Abstract
Background: Lower global disability and higher quality of life among ischemic stroke patients was found to be associated with the dispatch of mobile stroke units (MSUs) among patients eligible for recanalizing treatments in the Berlin_Prehospital Or Usual Delivery of stroke care (B_PROUD) study. The current study assessed the cost-utility and cost-effectiveness of additional MSU dispatch using data from this prospective, controlled, intervention study.
Methods: Outcomes considered in the economic evaluation included quality-adjusted life years (QALYs) derived from the 3-level version of EQ-5D (EQ-5D-3L) and modified Rankin Scale (mRS) scores for functional outcomes 3-months after stroke. Costs were prospectively collected during the study by the MSU provider (Berlin Fire Brigade) and the B_PROUD research team. We focus our results on the societal perspective. As we aimed to determine the economic consequences of the intervention beyond the study's follow-up period, both care costs and QALYs were extrapolated over 5 years.
Results: The additional MSU dispatch resulted in an incremental €40,984 per QALY. The best-case scenario and the worst-case scenario yielded additional costs of, respectively, €24,470.76 and €61,690.88 per QALY. In the cost-effectiveness analysis, MSU dispatch resulted in incremental costs of €81,491 per survival without disability. The best-case scenario and the worst-case scenario yielded additional costs of, respectively, €44,455.30 and €116,491.15 per survival without disability.
Interpretation: Among patients eligible for recanalizing treatments in ischemic stroke, MSU dispatch was associated with both higher QALYs and higher costs and is cost-effective when considering internationally accepted thresholds ranging from an additional €40,000 to €80,000 per QALY. ANN NEUROL 2023;93:942-951.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ana.26602 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prehospital stroke diagnostics using three different simulation methods: A pragmatic pilot study.
Eur Stroke J
December 2024
Department of Research, Norwegian Air Ambulance Foundation, Norway.
Introduction: The optimal pathway for ultra-early diagnostics and treatment in patients with acute stroke remains uncertain. The aim of this study was to investigate how three different methods of simulated, rural prehospital computed tomography (CT) affected the time to prehospital treatment decision in acute stroke.
Materials And Methods: In this pragmatic, simulation, pilot study of prehospital CT we investigated a conventional ambulance with transport to a standard care rural stationary CT machine managed by paramedics, a Mobile Stroke Unit (MSU), and a helicopter with a simulated CT machine.
Effects of Mobile Stroke Unit dispatch on blood pressure management and outcomes in patients with intracerebral haematoma: Results from the Berlin_Prehospital Or Usual Care Delivery in acute Stroke (B_PROUD) controlled intervention study.
Eur Stroke J
June 2024
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Introduction: In patients with acute intracerebral haemorrhage (ICH) and elevated systolic blood pressure (BP), guidelines suggest that systolic BP reduction to <140 mmHg should be rapidly initiated. Compared with conventional care, Mobile Stroke Units (MSUs) allow for earlier ICH diagnosis through prehospital imaging and earlier BP lowering.
Patients And Methods: ICH patients were prospectively evaluated as a cohort of the controlled B_PROUD-study in which MSU availability alone determined MSU dispatch in addition to conventional ambulance.
Sustaining a New Model of Acute Stroke Care: A Mixed-Method Process Evaluation of the Melbourne Mobile Stroke Unit.
Int J Health Policy Manag
August 2023
Public Health and Health Services Research, Stroke, The Florey Institute Neuroscience and Mental Health, Heidelberg, University of Melbourne, Melbourne, VIC, Australia.
Background: Internationally, Mobile Stroke Unit (MSU) ambulances have changed pre-hospital acute stroke care delivery. MSU clinical and cost-effectiveness studies are emerging, but little is known about important factors for achieving sustainability of this innovative model of care.
Methods: Mixed-methods study from the Melbourne MSU (operational since November 2017) process evaluation.
The Effect of Mobile Stroke Unit Care on Functional Outcomes: An Application of the Front-door Formula.
Epidemiology
September 2023
From the Institute of Public Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Background: The Berlin-based B_PROUD study was designed to assess the effect of mobile stroke unit (MSU) dispatch among ischemic stroke and transient ischemic attack (TIA) patients without contraindications to reperfusion treatments. However, a large proportion of patients for whom the MSU was dispatched did not ultimately receive MSU care. We estimated the causal effect of additional MSU care on 3-month functional outcomes among B_PROUD patients for whom an MSU was dispatched.
View Article and Find Full Text PDFEconomic Evaluation of a Mobile Stroke Unit Service in Germany.
Ann Neurol
May 2023
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität zu Berlin, Berlin, Germany.
Article Synopsis
- The study found that using mobile stroke units (MSUs) improved quality of life and reduced disability for ischemic stroke patients, but came with higher costs.
- The economic evaluation revealed that dispatching MSUs resulted in an incremental cost of €40,984 per quality-adjusted life year (QALY) gained, with varying scenarios showing costs ranging from €24,470.76 to €61,690.88 per QALY.
- Overall, MSU dispatch was deemed cost-effective according to accepted thresholds, meaning the benefits in patient quality of life justified the extra expenses involved.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!